|
|
Post by orlon on Apr 12, 2014 13:48:24 GMT -5
A 'reverse triangular merger with a shell'? What the hell is this guy talking about?
|
|
|
|
Post by orlon on Apr 7, 2014 12:54:12 GMT -5
Has anyone heard from SIERRA? I'm sure she would have the answers. Meanwhile, I think something if afoot within the FDA...to many doctors have to many connections/associations with other pharmaceutical companies or conflicting interests. A little like Congress...that is why it takes so long for legislation to get done, it has to pass through a lot of committees, each with a tasks, each member with one interest or another. All we can do is wait, but it's becoming harder to hold on.
|
|
|
|
Post by orlon on Mar 31, 2014 11:30:48 GMT -5
But...someone has to be buying some of the 17.6 million shares already traded right? Who?
|
|
|
|
Post by orlon on Mar 29, 2014 16:58:36 GMT -5
I've read a small portion of the FDA document and not being a science type don't fully understand the ins and outs of the trials. That said, I've also read the 'woe is me, we've been lied to by the company,' comments, as well as the 'I told you so' group. There's been two sides to this story, one by supported by Epstein(?) and George Rho, and the other by the doomsayers. The FDA BD raised issues and asked questions that need to be answered. The Company will be there to answer them. I don't see this as a one way street where the FDA's independent panel sits and scolds Mannkind for spending billions on a new therapy and wasting everyone's time. I see this as a discussion by professionals to see if this new therapy will benefit diabetics or not. Mannkind will certainly debate the promise of the therapy...and answer questions that need to be answered. This is a big moment for Mannkind and hopefully they will give it their best shot. My humble suggestion is this:Let's sit back, take a deep breath, and watch the joust on Tuesday.
|
|
|
|
Post by orlon on Mar 24, 2014 17:56:09 GMT -5
It appeared to me that the latest SA article was hastily thrown together. That being said, I agree that at least we're in the green, but nothing to cheer about. Four cents on over 12,000,000 shares trades indicates a battle going on.
|
|
|
|
Post by orlon on Nov 2, 2013 13:06:48 GMT -5
I agree but I believe something devious is afoot. Excellent phase III results, the PPS goes down and short interest goes up. NDA accepted by the FDA , the PPS goes down. All evidence points to some serious manipulation, but the big question is who is doing the manipulation.
|
|
|
|
Post by orlon on Oct 21, 2013 22:10:11 GMT -5
Excellent find. As you suggested, there are those on the YB who are suggested the lung cancer link with inhaled insulin. It is quite apparent those posters did not take the time to read the article.
|
|
|
|
Post by orlon on Sept 27, 2013 14:06:34 GMT -5
I noted before on the Agora board that Summer Street was somewhat disreputable. The best they were in several articles a few years ago was neutral...nothing bad to say yet nothing good....look for the wheat and avoid this chaff. I'm more concerned about the increasing short interest than the occasional negative articles. Read a post (can't remember if it was here or the YB) that suggested longs may be hedging their investment this way, which would make sense, but 49 million shares?
|
|
|
|
Post by orlon on Sept 17, 2013 11:44:35 GMT -5
Sorry....meant idea, not IAEA (whatever that means:))
|
|
|
|
Post by orlon on Sept 17, 2013 11:42:54 GMT -5
...also makes me wonder who conducted the due diligence on Deerfield for Mannkind, as well as who negotiated the terms and the IAEA to Al Mann.
|
|
